Established in Japan in 1991, the EPS Group was the first Japanese CRO to establish a subsidiary in China and started clinical development support services centered on Asia. Establishing EPS International Holdings Co., Ltd. (EPS International) in 2007 and EPS Ekishin (China) Co., Ltd. in 2008 strengthened EPS’ overseas business. EPS International continues to support the implementation of high-quality Asian and global clinical trials through business alliances with its subsidiaries and affiliates in Asia and with world-class CROs based in Europe, USA, and India. In April 2019, we formed a strategic business alliance with George Clinical Pty Ltd., headquartered in Australia.
In general, pharmaceutical and medical device companies are manufacturing companies that manufacture and sell drugs and devices; while CROs are service companies that provide clinical development operations as products. For us, “service is a product”. What we, as a service company, should aim for is to continuously provide stable services through process standardization and improvement. Nowadays, the establishment of a system that can continuously provide stable services is highly regarded as a valued technology.
In October 2019, EPS International created a new organizational structure with the aim of constantly growing to meet the needs of customers and the times. We will continue to practice the company's basic philosophy of “Contribute to the health industry through the creation of valuable solutions” and continue to search for optimal solutions with our customers. This is the spirit of the EPS “Ever Progressing System”, which is the origin of the company name. It is expected that the people who work here will grow while constantly changing and evolving; and that is what everyone expects.
We will continue to respond to your needs. Thank you for your continued support and guidance.